Quantum Gold Rush, page-366

I agree with you completely Recruiter10.

BRN and WBT have only one product and concentrate on developing and selling that one product. AXE have mining, biosensors and QC and I think this affects market sentiment but only slightly as is it clear who in the BOD is in charge of what in AXE. I am invested in all three, but I think BRN and WBT's products are easier to understand for the market than QC is as well. QC is generally is more in a primitive space than AI at the moment which has come quite a long way recently.

I still think the recent ANN about partnering with Max Kelson has completely fallen under the radar for the market and institutional investors. This hints massively on commercialisation soon in the QC space which may be a world first. I topped up recently when I could based on this news.

GLAH